5.0Top Rated Service 2026verified by TrustindexTrustindex verifies that the company has a review score above 4.5, based on reviews collected on Google over the past 12 months, qualifying it to receive the Top Rated Certificate.
A tiny retinal implant that restores useful central vision to people with one of the world's leading causes of blindness is about to go on sale across Europe, marking a major milestone not only for ophthalmology but also for the commercialisation of brain-computer interface technology.
US-based Science Corp has announced the European commercial launch of its PRIMA retinal implant after receiving CE marking under the European Union's Medical Device Regulation, allowing the device to be sold across 30 European countries.
Guides, pricing strategies, referral research, and weekly MSP acquisition lists.
8-Part MSP Growth & Acquisition Toolkit